Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01958346 · ClinicalTrials.gov registry record · NA

New Maneuver to Facilitate Fiberoptic Intubation for Difficult Airway

A NA study of Anticipated Difficult Airway, sponsored by Enrico Camporesi.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT01958346 is a NA study of Anticipated Difficult Airway that has completed, run by Enrico Camporesi. The registered enrollment target is 78 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01958346, a NA study of Anticipated Difficult Airway, has completed, sponsored by Enrico Camporesi.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

We propose the additional technique of lingual traction or "tongue pulling" in conjunction with use of the flexible fiberoptic bronchoscope for facilitating successful first attempts at and decreasing time to intubation of the difficult airway and rescuing otherwise failed intubation attempts. Induction of general anesthesia causes relaxation and approximation of the soft palate, base of the tongue, epiglottis, and posterior pharyngeal wall, creating unfavorable anatomic changes in the pharynx for successful intubation. The use of lingual traction can assist in diminishing these problems by clearing the tongue away from the soft palate and uvula and lifting the epiglottis from the posterior pharyngeal wall, especially in the unanticipated difficult airway patient.

Interventions

  • OTHER Sham
  • OTHER Lingual Traction
  • DEVICE Fiberoptic Intubation

Study Locations (1)

Florida

  • Tampa General Hospital - Tampa

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2012-06
Est. Completion 2013-11
Phase NA

Sponsor

Enrico Camporesi

1 total trials

What the Registry Record Tells You About NCT01958346

The ClinicalTrials.gov registry entry for NCT01958346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Enrico Camporesi, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anticipated Difficult Airway appearing as the primary indexed condition, and to 3 interventions - of which Sham is the first listed.

NCT01958346 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01958346 about?

NCT01958346 is a clinical study titled "New Maneuver to Facilitate Fiberoptic Intubation for Difficult Airway". We propose the additional technique of lingual traction or "tongue pulling" in conjunction with use of the flexible fiberoptic bronchoscope for facilitating successful first attempts at and decreasing time to intubation of the difficult airway and rescuing otherwise failed intubation attempts. Induc...

What is the current status of trial NCT01958346?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2012-06. Estimated completion is 2013-11.

What conditions does trial NCT01958346 study?

This clinical trial studies the following conditions: Anticipated Difficult Airway.

What interventions are being tested in trial NCT01958346?

The interventions under investigation include: Sham (OTHER), Lingual Traction (OTHER), Fiberoptic Intubation (DEVICE).

Who is sponsoring clinical trial NCT01958346?

This trial is sponsored by Enrico Camporesi, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01958346 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.